Taya Glotzer, M.D., FACC, FHRS, honored at the New Jersey Coronary heart Ball on June 10
Taya Glotzer, M.D., FACC, FHRS, has been named the American Heart Association’s (AHA) 2022 Researcher of the Yr. The award is offered to a researcher who is accomplishing cutting-edge research in the industry of heart disease and/or stroke.
“Research is a cornerstone of the American Coronary heart Affiliation and acknowledging persons who are building improvements is quite critical to us,” mentioned Peter Cary, govt director for the New Jersey region with the AHA. “Dr. Glotzer and her perform deserve recognition, and we are so grateful for her commitment to enable people today dwell for a longer period, healthier life.”
Dr. Glotzer, who is a professor of drugs at the Hackensack Meridian School of Medication and the director of Cardiac Investigation at Hackensack University Clinical Center, gained the award at the American Coronary heart Association’s yearly gala, the New Jersey Heart Ball, on June 10.
“Dr. Glotzer is one particular of our supremely proficient researcher-physicians,” mentioned Robert C. Garrett, CEO of Hackensack Meridian Well being. “We applaud her accomplishment.”
“We are so happy of Dr. Glotzer’s contributions to the wonderful science and innovation pushed by our community,” stated Ihor Sawczuk, M.D., FACS, president of Academics, Investigation and Innovation for Hackensack Meridian Overall health. “Our software to boost clinicians partaking in analysis carries on to pay out dividends for our sufferers – and national companies are noticing.”
Extensively revealed and invited often by businesses which includes the American College of Cardiology, American Coronary heart Affiliation, Heart Rhythm Society, and the European Modern society of Cardiology to present nationally and internationally, Dr. Glotzer has had a longstanding desire in the prevention of stroke, and in investigating the romance among atrial fibrillation (AF) and stroke.
She posted a single of the 1st papers figuring out the association of cardiac implanted machine detected AF with bad scientific results stroke and dying, in 2003. Dr. Glotzer was the primary investigator of a landmark trial (Trends), which showed that a product detected AF for a longer period than 5.5 hours in the the latest 30 days doubles the threat of stroke. She was component of the producing team for the Heart Rhythm Modern society Professional Consensus Assertion on Remote Checking, and for the European Coronary heart Rhythm Affiliation consensus document on Unit Detected Subclinical AF.
In response to the pandemic, Hackensack College Health care Center introduced a COVID-distinct cardiology study group, of which Dr. Glotzer is a member. The team is collaborating to drop light-weight on COVID’s effect on the heart and blood vessels. In this ability, Dr. Glotzer found abnormalities on admission EKGs that predicted very poor outcomes in people hospitalized with COVID-19. She introduced her findings at the Coronary heart Rhythm Society’s 2021 Yearly Scientific Periods.
Dr. Glotzer gained her medical degree from the New York University Faculty of Medicine in 1987, and did her residency, cardiology fellowship, and electrophysiology fellowship at NYU Langone Health-related Middle. She is board accredited in clinical cardiac electrophysiology. She has been director of Cardiac Exploration at Hackensack College Health-related Center due to the fact 2005, in addition to the entire-time practice of cardiac electrophysiology at Hackensack College Health-related Center. She is a fellow of the American Higher education of Cardiology, and a fellow of the Heart Rhythm Society. “I appreciate observing and dealing with my clients, some of whom I’ve acknowledged for 20 many years,” Dr. Glotzer stated. “I come to feel privileged to be equipped to consider treatment of them.”
For data about Hackensack Meridian Health’s cardiovascular solutions, stop by www.hackensackmeridianhealth.org/en/Products and services/Heart-Care. For information and facts about the Hackensack Meridian University of Medicine, go to www.hmsom.org/.
ABOUT HACKENSACK MERIDIAN College OF Medication
The Hackensack Meridian School of Drugs, the very first private health care college in New Jersey in a lot more than 50 several years, welcomed its initial class of students in 2018 to its On3 campus in Nutley and Clifton. Hackensack Meridian Health assumed its impartial operation in July 2020. The school’s vision is that just about every individual in New Jersey, and in the United States, no matter of race or socioeconomic status, will get pleasure from the greatest ranges of wellness in an economically and behaviorally sustainable style. The School’s exceptional curriculum focuses on linking the simple science with clinical relevance, as a result of an integrated curriculum in a group-oriented, collaborative environment. The faculty prides alone on outreach, by applications like the Human Dimension, which is lively in communities throughout New Jersey.
